Literature DB >> 22938939

A meta-analytic review of polyunsaturated fatty acid compositions in dementia.

Pao-Yen Lin1, Chih-Chiang Chiu, Shih-Yi Huang, Kuan-Pin Su.   

Abstract

OBJECTIVE: To determine whether the levels of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), arachidonic acid (AA), total n-3 polyunsaturated fatty acids (PUFAs), and total n-6 PUFAs were changed in patients with dementia or predementia syndrome. DATA SOURCES: PubMed was searched for studies from first date available to July 2011 using the following search terms: (dementia OR cognitive impairment OR mild cognitive impairment) AND (omega-3 OR omega-6 OR polyunsaturated fatty acid OR docosahexaenoic acid OR DHA OR eicosapentaenoic acid OR EPA). The search was limited to literature in English and to human studies. The references of relevant articles and review articles were searched for citations not indexed in PubMed. STUDY SELECTION: Studies were included if they measured levels of EPA, DHA, AA, total n-3 PUFAs, or total n-6 PUFAs from peripheral blood tissues in subjects with cognitive deficits (dementia or predementia syndrome) and elderly controls and were published in peer-reviewed journals. The search yielded 10 articles including 2,280 subjects. DATA EXTRACTION: The study design, sample size, PUFA levels for both patients and control subjects, sampling tissue, diagnoses and diagnostic criteria for cognitive deficits, and distribution of mean age and gender of included subjects were extracted for each study.
RESULTS: In a random-effects model, we found that the levels of EPA (effect size [ES] = -0.47, P < .0001), DHA (ES = -0.33, P = .017), and total n-3 PUFAs (ES = -0.46, P = .001) were decreased in patients with dementia. However, the levels of EPA (ES = -0.44, P = .002), but not DHA or other PUFAs, were significantly lower in patients with predementia syndrome.
CONCLUSIONS: Our results support the important role of n-3 PUFAs in the pathophysiology of dementia. In addition, the analyses of predementia studies indicate that EPA might be not only a disease-state marker but also a risk factor for cognitive impairment. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938939     DOI: 10.4088/JCP.11r07546

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  24 in total

1.  Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.

Authors:  Nurit Hadad; Rachel Levy
Journal:  Neuromolecular Med       Date:  2017-08-04       Impact factor: 3.843

2.  Dietary Vitamin E Status Dictates Oxidative Stress Outcomes by Modulating Effects of Fish Oil Supplementation in Alzheimer Disease Model APPswe/PS1dE9 Mice.

Authors:  Shengqi Dong; Xiaochen Huang; Jie Zhen; Nicholas Van Halm-Lutterodt; JiaJia Wang; Cui Zhou; Linhong Yuan
Journal:  Mol Neurobiol       Date:  2018-04-14       Impact factor: 5.590

3.  Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.

Authors:  Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Bruce M Psaty; David S Siscovick; Dariush Mozaffarian
Journal:  Circulation       Date:  2014-08-14       Impact factor: 29.690

4.  Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).

Authors:  Eric M Ammann; James V Pottala; Jennifer G Robinson; Mark A Espeland; William S Harris
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-06-15       Impact factor: 4.006

5.  Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment.

Authors:  E L Boespflug; R K McNamara; J C Eliassen; M D Schidler; R Krikorian
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

6.  Perilla Seed Oil Enhances Cognitive Function and Mental Health in Healthy Elderly Japanese Individuals by Enhancing the Biological Antioxidant Potential.

Authors:  Michio Hashimoto; Kentaro Matsuzaki; Shahdat Hossain; Tomoko Ito; Harumi Wakatsuki; Yoko Tanabe; Miho Ohno; Setsushi Kato; Kazuya Yamashita; Osamu Shido
Journal:  Foods       Date:  2021-05-19

7.  Polyunsaturated fatty acids in serum and homocysteine concentrations in Japanese men and women: a cross-sectional study.

Authors:  Ayami Kume; Kayo Kurotani; Masao Sato; Yuko Ejima; Ngoc Minh Pham; Akiko Nanri; Keisuke Kuwahara; Tetsuya Mizoue
Journal:  Nutr Metab (Lond)       Date:  2013-06-10       Impact factor: 4.169

Review 8.  Omega-3 fatty acids for the treatment of dementia.

Authors:  Marion Burckhardt; Max Herke; Tobias Wustmann; Stefan Watzke; Gero Langer; Astrid Fink
Journal:  Cochrane Database Syst Rev       Date:  2016-04-11

9.  Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders.

Authors:  Kuan-Pin Su; Yutaka Matsuoka; Chi-Un Pae
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-08-31       Impact factor: 2.582

Review 10.  Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA.

Authors:  Simon C Dyall
Journal:  Front Aging Neurosci       Date:  2015-04-21       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.